PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
Background: Despite the large use of inhibitors of Poly-ADP ribose polymerase (PARP-I), the feasibility and safety of their combination with radiotherapy (RT) is unclear. Aim: We conducted a literature analysis with the aim to evaluate the efficacy and safety profile of a combination with RT and PAR...
Guardado en:
Autores principales: | Amelia Barcellini, Pierre Loap, Kazutoshi Murata, Riccardo Villa, Youlia Kirova, Noriyuki Okonogi, Ester Orlandi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c236196a40cd44788e22d26676f07db4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
por: Wasyluk W, et al.
Publicado: (2021) -
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Desh Deepak Singh, et al.
Publicado: (2021) -
High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
por: Nishant Thakur, et al.
Publicado: (2021) -
Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis
por: Christopher A. Koczor, et al.
Publicado: (2021) -
Mechanisms of Nucleosome Reorganization by PARP1
por: Natalya V. Maluchenko, et al.
Publicado: (2021)